VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) fell 2.9% during mid-day trading on Tuesday . The company traded as low as C$0.17 and last traded at C$0.17. 105,487 shares changed hands during mid-day trading, a decline of 64% from the average session volume of 289,703 shares. The stock had previously closed at C$0.17.
VentriPoint Diagnostics Price Performance
The stock’s 50-day simple moving average is C$0.10 and its two-hundred day simple moving average is C$0.13. The firm has a market cap of C$24.33 million, a P/E ratio of -4.63 and a beta of 0.39. The company has a debt-to-equity ratio of -58.56, a current ratio of 0.28 and a quick ratio of 6.67.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Read More
- Five stocks we like better than VentriPoint Diagnostics
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- Technology Stocks Explained: Here’s What to Know About Tech
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
- What is a Dividend King?
- Joby Aviation: From Prototype to Profitability
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
